<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01918215</url>
  </required_header>
  <id_info>
    <org_study_id>CMRG-HF-1</org_study_id>
    <nct_id>NCT01918215</nct_id>
  </id_info>
  <brief_title>Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.</brief_title>
  <acronym>CMR_GUIDE</acronym>
  <official_title>Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Flinders University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>South Australian Health and Medical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Flinders University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Contemporary heart failure (HF) guidelines recommend insertion of a primary prevention
      implantable defibrillator (ICD) in patients with left ventricular ejection fraction less than
      35% (LVEF &lt; 35%) on maximally tolerated medical therapy. Nevertheless, there are a
      substantial number of HF patients who have LVEF&gt;35% and hence do not qualify for ICD, who
      succumb to sudden cardiac death (SCD). At present our tools to reliably risk stratify these
      patients with mild-moderate systolic dysfunction (LVEF 36-50%) are poor. It is likely that
      these patients have ventricular scar and/or replacement fibrosis as a substrate for their
      malignant arrhythmia. Cardiovascular magnetic resonance imaging (CMR) can reliably identify
      and quantify both ventricular scar (seen in Ischaemic cardiomyopathy, ICM) and replacement
      myocardial fibrosis (seen in Non-Ischemic Cardiomyopathy, NICM).

      Methods/Design: A multi-centre randomised controlled trial in which 428 patients with
      mild-moderate left-ventricular systolic dysfunction (either ICM or NICM) and ventricular
      scar/fibrosis on cardiovascular magnetic resonance are randomized to either ICD or
      implantable loop recorder (ILR) insertion and are followed up until the last patient
      recruited has been in the study for 3 years.

      Potentially eligible patients will have a screening CMR and will be enrolled into the device
      arm of study based on the presence of any ventricular scar/fibrosis (CMR +). Patients who do
      not have ventricular scar/fibrosis will be followed up in an observational registry, and will
      not be randomised.

      In both the device and registry arms, we aim to enrol 700 patients in Australia and 355 in
      Europe.

      The primary hypothesis is that among patients with mild-moderate left ventricular systolic
      dysfunction, a routine CMR guided management strategy of ICD insertion is superior to a
      conservative strategy of standard care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of Sudden Cardiac Death or haemodynamically significant ventricular arrhythmia</measure>
    <time_frame>Through to study completion, an average of 4 years</time_frame>
    <description>Defined as: ventricular arrhythmia producing syncope (loss of consciousness) or associated with hypotension (SBP&lt;90mmHg) except directly associated with device implant procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sudden Cardiac Death</measure>
    <time_frame>Through to study completion, an average of 4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamically significant ventricular arrhythmia</measure>
    <time_frame>Through to study completion, an average of 4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>Through to study completion, an average of 4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in New York Heart Association Functional class</measure>
    <time_frame>3, 6,12, 24, 36, 48 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure related hospitalizations</measure>
    <time_frame>Through to study completion, an average of 4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health economic evaluation of cost</measure>
    <time_frame>At study completion, average of 4 years</time_frame>
    <description>Australia only</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessed by Minnesota Living with Heart Failure Questionnaire</measure>
    <time_frame>3, 6,12, 24, 36, 48 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessed by EuroQol-5D-5L questionnaire</measure>
    <time_frame>3, 6,12, 24, 36, 48 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1055</enrollment>
  <condition>Heart Failure</condition>
  <condition>Left Ventricular Systolic Dysfunction</condition>
  <arm_group>
    <arm_group_label>Device Implantation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A prospective, blocked, randomised, placebo-controlled trial of primary prophylaxis ICD therapy or implantable loop recorder (ILR) insertion in patients with LVEF 36-50% and Late Gadolinium Enhancement(LGE)on CMR</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Observational Registry</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>A prospective observational registry of patients with LVEF 36-50% and no LGE on CMR</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ICD</intervention_name>
    <arm_group_label>Device Implantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ILR</intervention_name>
    <arm_group_label>Device Implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age equal or greater than 18 years

          -  Patients with coronary artery disease (CAD) or dilated cardiomyopathy (DCM) of the
             idiopathic, chronic post myocarditis or familial type.

          -  Left ventricular systolic impairment as defined by left ventricular ejection fraction
             36-50% by any current standard technique (echocardiogram, multiple gated acquisition
             scan (MUGA), angiography or CMR taken in the last six months. If a LGE CMR has been
             taken within 2 months this scan can be used for inclusion

          -  Able and willing to comply with all pre-, post- and follow-up testing, and
             requirements

          -  On maximum tolerated doses of ACE inhibitors (or Angiotensin and Receptor Blockers if
             intolerant of ACE) and Beta Blockers

        Exclusion Criteria:

          1. History of cardiac arrest or spontaneous or inducible sustained ventricular
             tachycardia or ventricular fibrillation unless within 48 hours of an acute MI

          2. Cardiomyopathy related to sarcoidosis

          3. Standard Cardiac Magnetic Resonance imaging contraindications (e.g. severe
             claustrophobia)

          4. Currently implanted permanent pacemaker and/or pacemaker/ICD lead

          5. Clinical indication for ICD or Pacemaker or cardiac resynchronisation therapy.

          6. CMR LVEF ≤35% or&gt;50%

          7. Severe renal insufficiency (eGFR&lt; 30mls/min/1.73m2)

          8. Recent Myocardial Infarction (MI) (&lt;40 days) or cardiac revascularization (&lt;90 days)

          9. New York Heart Association HF functional class IV at baseline

         10. Conditions associated with life expectancy &lt;1 year

         11. Pregnancy or in females of child-bearing potential, the non-use of accepted forms of
             contraception
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph B Selvanayagam, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Flinders Medical Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joseph B Selvanayagam, MBBS</last_name>
    <phone>+61 8 8404 2195</phone>
    <email>joseph.selvanayagam@flinders.edu.au</email>
  </overall_contact>
  <location>
    <facility>
      <name>John Hunter Hospital</name>
      <address>
        <city>New Lambton</city>
        <state>New South Wales</state>
        <zip>2305</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sukumaran Thambar, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gerald Kaye</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane &amp; Women's Hospital</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>John Younger</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Flinders Medical Centre</name>
      <address>
        <city>Bedford Park</city>
        <state>South Australia</state>
        <zip>5042</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Andrew McGavigan, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lyell McEwin Hospital</name>
      <address>
        <city>Elizabeth Vale</city>
        <state>South Australia</state>
        <zip>5112</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Margaret Arstall</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Hobart Hospital</name>
      <address>
        <city>Hobart</city>
        <state>Tasmania</state>
        <zip>7000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Paul McIntyre, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northern Hospital</name>
      <address>
        <city>Epping</city>
        <state>Victoria</state>
        <zip>3076</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>St Vincent's Hospital</name>
      <address>
        <city>Fitzroy</city>
        <state>Victoria</state>
        <zip>3065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>David Prior</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Alfred</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Kaye</last_name>
      <email>David.Kaye@bakeridi.edu.au</email>
    </contact>
    <investigator>
      <last_name>David M Kaye, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3084</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Sir Charles Gairdner Hospital</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <zip>6009</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Arieh Keren</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Perth Hospital</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nikola Stoyanov</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Coburg Hospital</name>
      <address>
        <city>Coburg</city>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Brachmann</last_name>
      <phone>+499561226348</phone>
      <email>johannes.brachmann@klinikum-coburg.de</email>
    </contact>
    <investigator>
      <last_name>Johannes Brachmann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus</name>
      <address>
        <city>Dusseldorf</city>
        <zip>40217</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ernst Vester</last_name>
      <phone>+49 211 9191 855</phone>
    </contact>
    <investigator>
      <last_name>Ernst Vester</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peter Osypka Herzzentrum, Klinikum Dr Muller</name>
      <address>
        <city>München</city>
        <zip>81379</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thorsten Lewalter</last_name>
      <phone>+49 89 72400 4399</phone>
      <email>thorsten.lewalter@mueller-klinik.de</email>
    </contact>
    <investigator>
      <last_name>Thorsten Lewalter</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Schwarzwald-Baar Klinikum</name>
      <address>
        <city>Villingen-Schwenningen</city>
        <zip>78052</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Werner Jung</last_name>
      <email>werner.jung@sbk-vs.de</email>
    </contact>
    <investigator>
      <last_name>Werner Jung</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Wurzburg</name>
      <address>
        <city>Wurzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Bauer</last_name>
      <phone>+49 931 201 39011</phone>
      <email>bauer_W@ukw.de</email>
    </contact>
    <investigator>
      <last_name>Wolfgang Bauer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Belfast Health and Social Care Trust</name>
      <address>
        <city>Belfast</city>
        <zip>BT12 6NT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicola Johnston</last_name>
      <phone>07837436605</phone>
      <email>nicola.johnston@belfasttrust.hscni.net</email>
    </contact>
    <investigator>
      <last_name>Nicola Johnston</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francisco Leyva, MD</last_name>
      <phone>+44 7071031789</phone>
      <email>francisco.keyva@uhb.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Francisco Leyva</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Bristol Heart Institute</name>
      <address>
        <city>Bristol</city>
        <zip>BS2 8HW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Nisbet</last_name>
      <phone>+44 7470 058675</phone>
      <email>Ashley.Nisbet@UHBristol.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Ashley Nisbet</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Golden Jubilee National Hospital</name>
      <address>
        <city>Clydebank</city>
        <zip>G814DY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derek Connelly</last_name>
      <phone>+44 141 951 5861</phone>
      <email>derek.connelly@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Derek Connelly</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Glenfield General Hospital</name>
      <address>
        <city>Leicester</city>
        <zip>LE39QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerry McCann</last_name>
      <phone>+44116 258 3038</phone>
      <email>gpm12@le.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Gerry McCann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Brompton Hospital</name>
      <address>
        <city>London</city>
        <zip>SW36NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sanjay Prasad</last_name>
      <phone>+44 20 7351 8802</phone>
      <email>s.prasad@rbht.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Sanjay Prasad</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of South Manchester NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <zip>M23 9LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Niall Campbell</last_name>
      <phone>0161 291 4168</phone>
      <email>niall.campbell@uhsm.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Niall Campbell</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Germany</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2013</study_first_submitted>
  <study_first_submitted_qc>August 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2013</study_first_posted>
  <last_update_submitted>February 13, 2018</last_update_submitted>
  <last_update_submitted_qc>February 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Flinders University</investigator_affiliation>
    <investigator_full_name>Joseph Selvanayagam</investigator_full_name>
    <investigator_title>Professor Joseph Selvanayagam</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

